HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Management of malignant epithelial tumors of the ovary].

Abstract
The notoriously poor prognosis of ovarian cancer requires optimal management by a multidisciplinary gynecologic and oncologic surgical team. Ovarian cancers which appear to be of early stage must be accurately staged to be sure that no potential metastatic sites are missed. Such an omission may have grave consequences for disease progression and may reduce the chances of cure in young patients. With advanced-stage ovarian carcinoma, the challenge is to perform a detailed pre-operative staging of the extent of disease to enable neo-adjuvant chemotherapy when the disease is judged to be inoperable and/or the the general condition of the patient is unsuitable for surgery. Only patients who have had complete cytoreductive surgery to all affected areas in the abdomen can hope to have an acceptable 5 year survival rate of 50%.
AuthorsC Pomel, J Dauplat
JournalJournal de chirurgie (J Chir (Paris)) Vol. 141 Issue 5 Pg. 277-84 (Sep 2004) ISSN: 0021-7697 [Print] France
Vernacular TitlePrise en charge chirurgicale des tumeurs épithéliales malignes de l'ovaire.
PMID15494657 (Publication Type: English Abstract, Journal Article, Review)
Topics
  • Carcinoma (pathology, surgery)
  • Female
  • Humans
  • Laparoscopy
  • Lymph Node Excision
  • Neoplasm Staging
  • Ovarian Neoplasms (pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: